Companies / United States
Pfizer Plans Future For OTC Business
April 2006 | Company Finance AlertUS giant Pfizer is considering options for its prestigious over-the-counter (OTC) healthcare unit, including a US$14bn sale, spinning off the division to shareholders, or retaining the business. A decision is expected in Q306.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
